Veeva SystemsVEEV
Price$285.45Intrinsic value$229.4120% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $229.41median of 6 methods · middle span $166-$308based on filings through 31 Jul 2026
Market Price $285.45Price as of 30 Sep 2026
Margin of Safety -19.6%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 11.6% (near-term consensus, capped) · years 2–5: 12.2%/yr (balance of the path).12.1% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 612.2%Yr 712.2%Yr 812.2%Yr 912.1%Yr 1012.1%
12.2% → 12.1%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1111.2%Yr 1210.3%Yr 139.4%Yr 148.5%Yr 157.6%Yr 166.6%Yr 175.7%Yr 184.8%Yr 193.9%Yr 203.0%
12.1% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)19.2%
Discount rate (cost of equity) 9.2%
Volatility vs market (adjusted beta)0.94

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetVeeva SystemsVEEVHealth Care
Valuation
P/E46.8×
P/S12.4×
P/B5.9×
EV / Revenue11.8×
EV / EBITDA—
Profitability
Gross margin75.0%
Operating margin29.9%
Net margin29.3%
FCF margin—
Returns
ROE13.7%
ROA11.2%
ROIC—
Growth
Revenue growth (YoY)25.9%
5-yr fwd EPS growth12.1%
Financial strength
Debt / Equity—
Current ratio5.46×
Altman Z-Score17.9
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.